Fisher & Paykel Healthcare Corporation Limited (FPLB) Stock Forecast & Price Target
1 Followers
FPLB Analyst Ratings
Strong Buy
6Buy2Hold0Sell
Based on 8 analysts giving stock ratings to Fisher & Paykel Healthcare Corporation Limited in the past 3 months
FPLB Stock 12 Month Forecast
Average Price Target
EUR 26.40▲(13.81% Upside)Based on 8 Wall Street analysts offering 12 month price targets for Fisher & Paykel Healthcare Corporation Limited in the last 3 months. The average price target is EUR 26.40 with a high forecast of EUR 28.38 and a low forecast of EUR 25.41. The average price target represents a 13.81% change from the last price of EUR 23.20.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 28.38
AverageEUR 26.40
LowEUR 25.41
Highest Price TargetHighestEUR 28.38Average Price TargetEUR 26.40Lowest Price TargetLowestEUR 25.41
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Marcus Curley | UBS | EUR 20.92→EUR 25.41 | hold | 9.52%Upside | Reiterated | 11/04/26 | ||
| Vanessa Thomson | Jefferies | EUR 26.36→EUR 28.38 | buy | 22.32%Upside | Reiterated | 10/29/26 | ||
| Craig Wong-Pan | RBC Capital | EUR 19.43→EUR 25.91 | buy | 11.67%Upside | Upgraded | 09/15/26 | ||
| Laura Sutcliffe | Citi | EUR 19.93→EUR 25.41 | buy | 9.52%Upside | Upgraded | 09/10/26 | ||
| David Bailey | Morgan Stanley | ― | buy | ― | Reiterated | 08/24/26 | ||
| Adrian Allbon | Jarden | ― | hold | ― | Reiterated | 08/24/26 | ||
| Chris Cooper | J.P. Morgan | EUR 26.92 | buy | 16.04%Upside | Reiterated | 08/24/26 | ||
 Unknown AnalystNot Ranked | Macquarie | ― | buy | ― | Reiterated | 08/23/26 | ||
| Shane Storey | Canaccord Genuity | EUR 22.64 | buy | -2.41%Downside | Reiterated | 05/27/26 | ||
| Davinthra Thillainathan | Goldman Sachs | EUR 26.55→EUR 27.35 | buy | 17.91%Upside | Reiterated | 02/23/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Marcus CurleyUBS | HoldReiteratedEUR 20.92→EUR 25.41 | 11/04/26 | 9.52%Upside | ||
| Vanessa ThomsonJefferies | BuyReiteratedEUR 26.36→EUR 28.38 | 10/29/26 | 22.32%Upside | ||
| Craig Wong-PanRBC Capital | BuyUpgradedEUR 19.43→EUR 25.91 | 09/15/26 | 11.67%Upside | ||
| Laura SutcliffeCiti | BuyUpgradedEUR 19.93→EUR 25.41 | 09/10/26 | 9.52%Upside | ||
| David BaileyMorgan Stanley | BuyReiterated | 08/24/26 | ― | ||
| Adrian AllbonJarden | HoldReiterated | 08/24/26 | ― | ||
| Chris CooperJ.P. Morgan | BuyReiteratedEUR 26.92 | 08/24/26 | 16.04%Upside | ||
| Unknown AnalystMacquarieNot Ranked | BuyReiterated | 08/23/26 | ― | ||
| Shane StoreyCanaccord Genuity | BuyReiteratedEUR 22.64 | 05/27/26 | -2.41%Downside | ||
| Davinthra ThillainathanGoldman Sachs | BuyReiteratedEUR 26.55→EUR 27.35 | 02/23/26 | 17.91%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Fisher & Paykel Healthcare Corporation Limited
3 Months
Success Rate5/6 ratings generated profit
83%
Average Return
+16.38%
Copying Chris Cooper's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +16.38% per trade.
1 Year
Success Rate4/4 ratings generated profit
100%
Average Return
+19.82%
Copying Christine Trinh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.82% per trade.
2 Years
Success Rate5/5 ratings generated profit
100%
Average Return
+29.64%
Copying Davinthra Thillainathan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +29.64% per trade.
FPLB Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 9 | 5 | 8 | 8 | 4 |
| Hold | 7 | 6 | 6 | 4 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 11 | 14 | 12 | 5 |
In the current month, FPLB has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. FPLB average Analyst price target in the past 3 months is 26.40.
FPLB Financial Forecast
HighEUR 0.24
ConsensusEUR 0.23
LowEUR 0.21
FPLB Earnings Forecast
Next quarter’s earnings estimate for FPLB is EUR 0.23 with a range of EUR 0.21 to EUR 0.24. The previous quarter’s EPS was EUR 0.22. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 634M
ConsensusEUR 620M
LowEUR 602M
FPLB Sales Forecast
Next quarter’s sales forecast for FPLB is EUR 620.13M with a range of EUR 602.18M to EUR 633.92M. The previous quarter’s sales results were EUR 620.93M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
FPLB Stock Forecast FAQ
What is DE:FPLB’s average 12-month price target, according to analysts?
Based on analyst ratings, Fisher & Paykel Healthcare Corporation Limited’s 12-month average price target is €26.40.
What is DE:FPLB’s upside potential, based on the analysts’ average price target?
Fisher & Paykel Healthcare Corporation Limited has 13.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fisher & Paykel Healthcare Corporation Limited a Buy, Sell or Hold?
Fisher & Paykel Healthcare Corporation Limited has a consensus rating of Strong Buy, which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is Fisher & Paykel Healthcare Corporation Limited’s share price target?
The average share price target for Fisher & Paykel Healthcare Corporation Limited is €26.40. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €28.38, and the lowest forecast is €25.41. The average share price target represents a 13.81% increase from the current price of €23.2.
What do analysts say about Fisher & Paykel Healthcare Corporation Limited?
Fisher & Paykel Healthcare Corporation Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Fisher & Paykel Healthcare Corporation Limited?
To buy shares of DE:FPLB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
